Arcellx (ACLX) Tax Provisions (2023 - 2025)
Arcellx (ACLX) recorded quarterly Tax Provisions of $40000.0 in Q4 2025, up 37.93% quarter-over-quarter from $29000.0 in Q2 2025, and down 97.34% on a YoY basis from $1.5 million in Q4 2024.
Arcellx (ACLX) Tax Provisions (2023 - 2025) Analysis & Trends
Arcellx's Tax Provisions history runs 3 years deep, the most recent figure standing at $40000.0 for Q4 2025.
- In Q4 2025, Tax Provisions fell 97.34% year-over-year to $40000.0; the TTM figure through Dec 2025 stood at $69000.0 (down 96.56% YoY), while the FY2025 annual figure was $69000.0, down 96.67% from the prior year.
- Tax Provisions was $40000.0 for Q4 2025 at Arcellx, up from $29000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $1.5 million in Q4 2024 to a low of -$282000.0 in Q2 2023.
- Historically, Tax Provisions has averaged $304111.1 across 3 years, with a median of $200000.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions soared 3433.33% in 2024, then slumped 97.34% in 2025.
- A 3-year view of Tax Provisions shows it stood at $622000.0 in 2023, then jumped by 141.96% to $1.5 million in 2024, then plunged by 97.34% to $40000.0 in 2025.
- The last three Tax Provisions figures came in at $40000.0 (Q4 2025), $29000.0 (Q2 2025), and $1.5 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Dec 31, 2023 | 622,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -282,000.00 |
| Mar 31, 2023 | 329,000.00 |